Agenus Inc (AGEN) stock
AGENNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$6.29−0.44 (-6.54%)
Close on Nov 16, 2026Market cap $283.18MP/E –Yield –
Agenus total assets
Total assets on the balance sheet at the end of each period.
Agenus's total assets was $172.69M at Jun 30, 2026. For fiscal 2025 it was $226.80M, up 0.2% from the year before. Over ten years it grew -0.7% a year on average. The highest annual figure on record is $465.96M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $226.80M | +0.2% |
| FY2024 | Dec 31, 2024 | $226.27M | -27.9% |
| FY2023 | Dec 31, 2023 | $313.91M | -24.1% |
| FY2022 | Dec 31, 2022 | $413.56M | -11.2% |
| FY2021 | Dec 31, 2021 | $465.96M | +117.2% |
| FY2020 | Dec 31, 2020 | $214.51M | +38.1% |
| FY2019 | Dec 31, 2019 | $155.34M | +13.9% |
| FY2018 | Dec 31, 2018 | $136.40M | -1.4% |
| FY2017 | Dec 31, 2017 | $138.40M | -11.8% |
| FY2016 | Dec 31, 2016 | $156.99M | -35.2% |
| FY2015 | Dec 31, 2015 | $242.23M | +225.0% |
| FY2014 | Dec 31, 2014 | $74.53M | +113.9% |
| FY2013 | Dec 31, 2013 | $34.84M | +19.7% |
| FY2012 | Dec 31, 2012 | $29.09M | +46.9% |
| FY2011 | Dec 31, 2011 | $19.81M | -35.9% |
| FY2010 | Dec 31, 2010 | $30.91M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $172.69M | -6.8% |
| Q1 FY2026 | Mar 31, 2026 | $186.46M | -6.9% |
| Q4 FY2025 | Dec 31, 2025 | $226.80M | +0.2% |
| Q3 FY2025 | Sep 30, 2025 | $233.89M | -1.9% |
| Q2 FY2025 | Jun 30, 2025 | $185.22M | -36.7% |
| Q1 FY2025 | Mar 31, 2025 | $200.20M | -22.0% |
| Q4 FY2024 | Dec 31, 2024 | $226.27M | -27.9% |
| Q3 FY2024 | Sep 30, 2024 | $238.48M | -28.9% |
| Q2 FY2024 | Jun 30, 2024 | $292.42M | -23.8% |
| Q1 FY2024 | Mar 31, 2024 | $256.56M | -37.9% |
| Q4 FY2023 | Dec 31, 2023 | $313.91M | -24.1% |
| Q3 FY2023 | Sep 30, 2023 | $335.47M | -21.8% |
| Q2 FY2023 | Jun 30, 2023 | $383.59M | -15.9% |
| Q1 FY2023 | Mar 31, 2023 | $412.85M | -6.4% |
| Q4 FY2022 | Dec 31, 2022 | $413.56M | -11.2% |
| Q3 FY2022 | Sep 30, 2022 | $429.02M | -2.0% |
| Q2 FY2022 | Jun 30, 2022 | $456.17M | +137.2% |
| Q1 FY2022 | Mar 31, 2022 | $441.31M | +87.9% |
| Q4 FY2021 | Dec 31, 2021 | $465.96M | +117.2% |
| Q3 FY2021 | Sep 30, 2021 | $437.64M | +114.0% |
| Q2 FY2021 | Jun 30, 2021 | $192.30M | +3.5% |
| Q1 FY2021 | Mar 31, 2021 | $234.92M | +30.5% |
| Q4 FY2020 | Dec 31, 2020 | $214.51M | +38.1% |
| Q3 FY2020 | Sep 30, 2020 | $204.48M | +17.0% |
| Q2 FY2020 | Jun 30, 2020 | $185.78M | -10.1% |
| Q1 FY2020 | Mar 31, 2020 | $180.06M | -26.8% |
| Q4 FY2019 | Dec 31, 2019 | $155.34M | +13.9% |
| Q3 FY2019 | Sep 30, 2019 | $174.81M | +34.0% |
| Q2 FY2019 | Jun 30, 2019 | $206.71M | +56.7% |
| Q1 FY2019 | Mar 31, 2019 | $245.93M | +88.0% |
| Q4 FY2018 | Dec 31, 2018 | $136.40M | -1.4% |
| Q3 FY2018 | Sep 30, 2018 | $130.48M | -12.6% |
| Q2 FY2018 | Jun 30, 2018 | $131.94M | -25.2% |
| Q1 FY2018 | Mar 31, 2018 | $130.82M | -35.6% |
| Q4 FY2017 | Dec 31, 2017 | $138.40M | -11.8% |
| Q3 FY2017 | Sep 30, 2017 | $149.27M | -14.6% |
| Q2 FY2017 | Jun 30, 2017 | $176.49M | – |
| Q1 FY2017 | Mar 31, 2017 | $203.27M | – |
| Q4 FY2016 | Dec 31, 2016 | $156.99M | – |
| Q3 FY2016 | Sep 30, 2016 | $174.84M | – |
See a number that looks wrong?